Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful?
NCT ID: NCT00540748
Last Updated: 2010-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
400 participants
INTERVENTIONAL
2007-10-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxytocin Versus, Sublingual Misoprostol in the Secondary Prevention of Postpartum Hemorrhage After Vaginal Delivery
NCT05077540
Sublingual vs Intrauterine MISOPROSTOL Plus Oxytocin Infusion for Prevention of Post-cesarean Hemorrhage in High Risk Pregnant Women: A Double-blind Placebo RCT
NCT04560218
Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion
NCT02485444
Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage
NCT01113229
Ketamine Versus Fentanyl for Surgical Abortions
NCT04871425
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A1
oxytocin
5 U i.v. during surgical abortion
A2
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oxytocin
5 U i.v. during surgical abortion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* first trimester
* surgical intervention
* no current medication
* fluent in norwegian language
Exclusion Criteria
* medical condition with coagulopathy
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asker & Baerum Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asker and Baerum Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annelill Valbo, consultant, MD PhD
Role: STUDY_DIRECTOR
Kvinneklinikken SABHF
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kvinneklinikken SABHF
Baerum, Rud, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
392-06154 1.2006.1683 (REK)
Identifier Type: -
Identifier Source: secondary_id
392-06154 1.2006.1683 (REK)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.